marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Leap Therapeutics Income Statement 2011-2024 | LPTX
Annual Income Statement Leap Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
43.8 M | 3.51 M | 278 M | 178 M | 42.2 M | 30.8 M | 64.4 M | 68.6 M | - | - | - | - | - |
Shares |
20.4 M | 11.3 M | 85.8 M | 76.3 M | 22.6 M | 14.1 M | 9.16 M | 9.39 M | - | - | - | - | - |
Historical Prices |
2.14 | 0.31 | 3.24 | 2.25 | 1.12 | 2 | 6.24 | - | - | - | - | - | - |
Net Income |
-81.4 M | -54.6 M | -40.6 M | -27.5 M | -32.9 M | -23.1 M | -29.7 M | -25.6 M | -21.1 M | -25.5 M | -18.3 M | -7.76 M | - |
Revenue |
- | - | 1.5 M | 1.5 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 1.5 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-87 M | -56.8 M | -41.4 M | -28.5 M | -33.5 M | -30.8 M | -32.4 M | -27.3 M | - | - | - | - | - |
Interest Expense |
- | 54 K | 41 K | 39 K | 23 K | 19 K | 528 K | -9 K | - | - | - | - | - |
EBITDA |
-87 M | -56.7 M | -41.4 M | -28.3 M | -33.3 M | -29.9 M | -32.3 M | -24.4 M | -20.5 M | -19.7 M | -13.2 M | -6.98 M | - |
Operating Expenses |
87 M | 56.8 M | 42.9 M | 29.8 M | 33.3 M | 30 M | 32.4 M | - | - | - | - | - | - |
General and Administrative Expenses |
13.8 M | 11.8 M | 10.8 M | 9.62 M | 9.08 M | 8.92 M | 9.85 M | 4.23 M | 5.72 M | 4.71 M | 4.57 M | 1.51 M | - |
All numbers in USD currency
Quarterly Income Statement Leap Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
41.2 M | 39.1 M | 27 M | 25.6 M | 27 M | 14.7 M | 12.9 M | 9.9 M | 11.3 M | 11.3 M | 113 M | 88.3 M | 78.2 M | 76.4 M | 76.4 M | 59.7 M | 76.3 M | 52.4 M | 31.6 M | 24.2 M | 23.9 M | 22.9 M | 19.2 M | 14.7 M | 14.7 M | 14.7 M | 12.4 M | 12.4 M | 9.4 M | 9.39 M | 6.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-18.2 M | -20.1 M | -13.8 M | - | -13.7 M | -13.4 M | -41.9 M | - | -15.1 M | -17 M | -10.4 M | - | -11.1 M | -9.53 M | -9.13 M | - | -7.06 M | -6.52 M | -7.23 M | - | -7.94 M | -8.37 M | -8.6 M | - | -6.63 M | -7.36 M | -10.6 M | - | -6.82 M | -6.9 M | -9.41 M | - | -7.28 M | -7.48 M | -5.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | 375 K | 375 K | 375 K | - | 375 K | 375 K | 375 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-17.9 M | -21.3 M | -14.8 M | - | -14.8 M | -14.7 M | -42.7 M | - | -15.3 M | -16.9 M | -10.6 M | - | -12.1 M | -9.63 M | -9.17 M | - | -7.51 M | -7.5 M | -6.38 M | - | -7.92 M | -8.46 M | -8.8 M | - | -8.6 M | -6.84 M | -6.34 M | - | -8.58 M | -7.02 M | -10.2 M | - | -7.03 M | -7.19 M | -5.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | 11 K | 17 K | 21 K | - | 9 K | 16 K | 14 K | - | 17 K | 13 K | 12 K | - | 5 K | 9 K | 7 K | - | 4 K | 8 K | 6 K | - | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -14.8 M | - | - | - | -42.7 M | - | -15.3 M | -16.9 M | -10.6 M | - | -12.1 M | -9.61 M | -9.16 M | - | -7.48 M | -7.48 M | -6.37 M | - | -7.89 M | -8.44 M | -8.78 M | - | -8.56 M | -6.81 M | -6.33 M | - | -8.55 M | -6.99 M | -10.2 M | - | -7.01 M | -7.19 M | -5.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
17.9 M | 21.3 M | 14.8 M | - | 14.8 M | 14.7 M | 42.7 M | - | 15.3 M | 16.9 M | 10.6 M | - | 12.5 M | 10 M | 9.55 M | - | 7.88 M | 7.87 M | 6.76 M | - | 7.92 M | 8.46 M | 8.8 M | - | 8.6 M | 6.84 M | 6.34 M | - | 8.58 M | 7.02 M | 10.2 M | - | 7.03 M | 7.19 M | 5.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.94 M | 3.37 M | 3.53 M | - | 3.33 M | 3.56 M | 3.78 M | - | 3.19 M | 2.86 M | 2.85 M | - | 2.44 M | 2.8 M | 2.74 M | - | 2.51 M | 2.52 M | 2.15 M | - | 2.15 M | 2.32 M | 2 M | - | 2.14 M | 2.6 M | 2.11 M | - | 1.78 M | 2.14 M | 3.8 M | - | 1.37 M | 1.07 M | 1.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency